Clinical trial

The Effects of tDCS on Depressive Symptoms,Neurocognitive Function and HRV in Unipolar Depression and Bipolar Depression

NCT03287037

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention tDCS over DLPFC Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Effects of tDCS on Depressive Symptoms,Neurocognitive Function and HRV in Unipolar Depression and Bipolar Depression

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-10-01

PhaseNA

Conditions

Depressive Disorder, Majorunresolved

Depression, Bipolarunresolved

Electricity; Effectsunresolved

Interventions

tDCS over DLPFCDEVICE

Sponsors & collaborators

Tri-Service General Hospital (TSGH)lead sponsor

Mapped research locations

TaipeiTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03287037 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.